Page last updated: 2024-09-04

zosuquidar trihydrochloride and hederagenin

zosuquidar trihydrochloride has been researched along with hederagenin in 1 studies

Compound Research Comparison

Studies
(zosuquidar trihydrochloride)
Trials
(zosuquidar trihydrochloride)
Recent Studies (post-2010)
(zosuquidar trihydrochloride)
Studies
(hederagenin)
Trials
(hederagenin)
Recent Studies (post-2010) (hederagenin)
601131089

Protein Interaction Comparison

ProteinTaxonomyzosuquidar trihydrochloride (IC50)hederagenin (IC50)
Tissue factorHomo sapiens (human)0.0002
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)0.8913
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)3.8019

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, Y; Liu, XX; Qi, JG; Ren, QW; Tian, JW; Wang, BH; Wang, HB; Wang, X; Yang, YT; Zhai, R1

Other Studies

1 other study(ies) available for zosuquidar trihydrochloride and hederagenin

ArticleYear
Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
    European journal of medicinal chemistry, 2019, Jan-01, Volume: 161

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Oleanolic Acid; Structure-Activity Relationship; Tumor Cells, Cultured

2019